Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 727-732

  Hisatomi, Hisashi ^a   Nagao, Kumi ^a   Kanamaru, Taichi ^b   Endo, Hitoshi ^c   Tomimatsu, Masahiko ^c   Hikiji, Kazumasa ^a  

^a SRL INC   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

F TRAP; Hepatocellular carcinoma; Human telomerase reverse transcriptase; Telomerase

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; RNA; TELOMERASE; TELOMERASE RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CATALYSIS; FEMALE; GENETICS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATALYSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RNA; RNA, MESSENGER; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033109971     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.727     Document Type: Article

References (37)

1. Moyzis RK, Buckingham JM, Cram SH, et al: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988.
2. Hastie ND, Dempster M, Dunlop MG, et al: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990.
3. Chang E and Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
4. Yu GL, Bradley JD, Attardi LD, et al: In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132, 1990.
5. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
6. Hiyama K, Hiyama E, Ishioka S, et al: Telomerase activity in small cell and non-small cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
7. Nouso K, Urabe Y, Higashi T, et al: Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 78: 232-236, 1996.
8. Kojima H, Yokosuka O, Imazeki F, et al: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112: 493-500, 1996.
9. Feng J, Funk WD, Wang S, et al: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
10. Blasco MA, Rizen M, Greider CW, et al: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12: 200-204, 1996.
11. Avilion AA, Piatyszek MA, Gupta J, et al: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650, 1996.
12. Nakamura TM, Morin GB, Chapman KB, et al: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
13. Meyerson M, Couter CM, Eaton EN, et al: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997.
14. Nakayama J, Tahara H, Tahara E, et al: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68, 1998.
15. Murakami Y, Hayashi K, Hirohashi S, et al: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520-5525, 1991.
16. Ueda H, Ullrich SJ, Gangemi JD, et al: Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9: 41-47, 1995.
17. Buetow KH, Murray JC, Israel JL, et al: Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852-8856, 1989.
18. Shiota G, Okano J, Kawasaki H, et al: Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 21: 106-112, 1995.
19. Aden DP, Fogel A, Plotkin S, et al: Controlled synthesis of HBsAg in a differentiated human liver carcinoma derived cell line. Nature 282: 615-616, 1979.
20. Chomczynski P and Sacchi N: Single-step of RNA isolation by acid guamidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
21. Heid AC, Stevebs J, Livak KJ, et al: Real time quantitative PCR. Genome Res 6: 986-994, 1996.
22. Hisatomi H, Nagao K and Komatsu H: Quantification of telomerase activity in human liver tissues by fluorescence-based TRAP analysis. Hepatol Res 7: 35-42, 1997.
23. Kubota Y, Nakada T, Sasagawa I, et al: Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 713-717, 1998.
24. Kanamaru T, Morita Y, Ito T, et al: Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma. Jpn J Cancer Res 89: 727-732, 1998.
25. Wada E, Hisatomi H, Moritoyo T, et al: Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA. Oncol Rep 5: 1407-1412, 1998.
26. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
27. Nakashio R, Kitamoto M, Tahara H, et al: Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 74: 141-147, 1997.
28. Ide T, Tahara H, Nakashio R, et al: Telomerase in hepatocellular carcinogenesis. Hum Cell 9: 283-286, 1996.
29. Ohta K, Kanamaru T, Morita Y, et al: Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence. J Gastroenterol 32: 791-796, 1997.
30. Suda T, Isokawa O, Aoyagi Y, et al: Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent disease in the remnant liver. Hepatology 27: 402-406, 1998.
31. Weinberg RA: Oncogene, antioncogenes, and the molecular basis of multistep cancinogenesis. Cancer Res 49: 3713-3721, 1989.
32. Holt S, Norton JC, Wright WE, et al: Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 18: 237-248, 1996.
33. Brein TP, Kallakury BV, Lowry CV, et al: Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 57: 2760-2764, 1997.
34. Mao L, El-Naggar AK, Fan YH, et al: Telomerase activity in head and neck squamous cell carcinoma and adjacent tissue. Cancer Res 56: 5600-5604, 1996.
35. Dalbagni G, Han W, Zhang ZF, et al: Evaluation of the telomeric repeat amplification (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 3: 1593-1598, 1997.
36. Suchara N, Mizomoto K, Muta T, et al: Telomerase elevation in pancreatic ductal carcinoma compared to non-malignant pathological states. Clin Cancer Res 3: 993-998, 1997.
37. Holt SE, Aisner DL, Shay JW, et al: Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 94: 10687-10692, 1997.